Patient-Reported Outcome Of Facial Erythema (PROOF)
Status:
Completed
Trial end date:
2013-11-14
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the patient-reported outcomes (feedbacks of
patients)of a new drug for the treatment of erythema of rosacea (central facial redness). The
feedback of patients receiving the active drug will be compared to the feedback of patients
receiving the placebo.